---
layout: default
title: Activated Charcoal Apis Mellifera Arsenic Trioxide
parent: 僅模型預測 (L5)
nav_order: 192
evidence_level: L5
indication_count: 0
---

# Activated Charcoal Apis Mellifera Arsenic Trioxide
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Component Homeopathic Mixture: Insufficient Data for Repurposing Evaluation

---

## One-Sentence Summary

The submitted entry is a 12-component mixture that includes homeopathic ingredients (snake venoms, plant extracts, nosodes, and activated charcoal), none of which share a single DrugBank identifier or approved indication in the US.
The TxGNN model returned **no predicted indications** for this entry, most likely because the compound is not representable as a single chemical entity in the knowledge graph.
Without a mappable drug node, repurposing evaluation cannot proceed under the current pipeline.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | No approved indication on record |
| Predicted New Indication | None — model returned no candidates |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 (model prediction only — not applicable; no candidates generated) |
| US Market Status | Not marketed (0 active authorizations) |
| Number of NDAs | 0 |
| Recommended Decision | **Hold** |

---

## Why No Prediction Was Generated

This entry is a **multi-ingredient complex mixture** containing 12 distinct components:

| # | Component | Category |
|---|-----------|----------|
| 1 | Activated Charcoal | Adsorbent |
| 2 | Apis Mellifera (honeybee) | Homeopathic |
| 3 | Arsenic Trioxide | Metalloid / Homeopathic (Arsenicum album) |
| 4 | Atropa Belladonna | Anticholinergic alkaloid / Homeopathic |
| 5 | Bacillus Anthracis Immunoserum Rabbit | Nosode (homeopathic preparation) |
| 6 | Baptisia Tinctoria Root | Herbal / Homeopathic |
| 7 | Crotalus Horridus Horridus Venom | Snake venom / Homeopathic |
| 8 | Echinacea Angustifolia Whole | Herbal immunostimulant |
| 9 | Hyoscyamus Niger | Anticholinergic alkaloid / Homeopathic |
| 10 | Lachesis Muta Venom | Snake venom / Homeopathic |
| 11 | Rancid Beef | Nosode (homeopathic preparation) |
| 12 | Rhododendron Tomentosum Leafy Twig | Herbal / Homeopathic |

The TxGNN knowledge graph is built on single-entity drug nodes mapped via DrugBank IDs.
This mixture has **no DrugBank ID**, and its individual components — presented as a concatenated string — cannot be resolved to a single node in the graph.
As a result, the prediction pipeline produced zero candidates, which is the expected behavior for unresolvable multi-component entries.

The ingredient profile is consistent with a **homeopathic sepsis or acute infection nosode complex** (e.g., products historically formulated for bacterial toxemia, snakebite, or immune crisis in the homeopathic tradition). However, this clinical context is not verifiable from the data provided.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline cannot evaluate a 12-component mixture lacking a DrugBank anchor; the absence of any approved indication or market authorization further prevents safety and mechanistic cross-referencing. This entry should not advance to repurposing assessment in its current form.

**To proceed, the following is needed:**

- **Decompose the mixture**: Submit each component individually (e.g., Arsenic Trioxide, Echinacea Angustifolia, Activated Charcoal) through the pipeline. Arsenic Trioxide (DrugBank: DB01169, Trisenox) is already approved for acute promyelocytic leukemia and has existing TxGNN mappings.
- **Identify the intended formulation**: Confirm whether this is a homeopathic product (OTC nosode), a compounded preparation, or a misformatted regulatory filing. This changes the applicable regulatory pathway entirely.
- **Resolve the INN format**: The semicolon-delimited ingredient list is not a valid INN. If this is a single-product filing, obtain the product's brand name and NDC/NDA number to enable correct regulatory lookup.
- **Manual MOA and safety review**: If individual components are to be evaluated separately, retrieve DrugBank entries for each active ingredient, focusing particularly on Arsenic Trioxide (known cytotoxin with established MOA) and the anticholinergic alkaloids (Belladonna, Hyoscyamus Niger).
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

